Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Change in Cash (2020 - 2023)

Terns Pharmaceuticals' Change in Cash history spans 4 years, with the latest figure at $42.0 million for Q4 2023.

  • For Q4 2023, Change in Cash fell 47.63% year-over-year to $42.0 million; the TTM value through Dec 2023 reached -$63.3 million, down 166.27%, while the annual FY2025 figure was $363.3 million, 345.71% up from the prior year.
  • Change in Cash reached $42.0 million in Q4 2023 per TERN's latest filing, up from -$43.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $80.3 million in Q4 2022 to a low of -$103.4 million in Q2 2023.
  • Average Change in Cash over 4 years is $4.2 million, with a median of -$1.7 million recorded in 2020.
  • The largest YoY upside for Change in Cash was 3899.52% in 2021 against a maximum downside of 495.74% in 2021.
  • A 4-year view of Change in Cash shows it stood at $61.0 million in 2020, then tumbled by 127.93% to -$17.1 million in 2021, then soared by 570.67% to $80.3 million in 2022, then plummeted by 47.63% to $42.0 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Change in Cash are $42.0 million (Q4 2023), -$43.0 million (Q3 2023), and -$103.4 million (Q2 2023).